National Institute of Standards and Technology researchers at the Institute for Bioscience and Biotechnology Research have demonstrated the most precise method yet to measure the structural configuration of monoclonal antibodies (mAbs), an important factor in determining the safety and efficacy of these biomolecules as medicines.
from The Medical News http://ift.tt/1INmbS7
from The Medical News http://ift.tt/1INmbS7
No comments:
Post a Comment